Dr. Mieyal is a Vice President and the Director of Life Sciences Investments of Wexford Capital LLC. Prior to that, he was Vice President in charge of health care investments for Wechsler & Co., Inc. a private investment firm and registered broker dealer. Dr. Mieyal serves as director of Nile Therapeutics, Inc., and several privatecompanies. Dr. Mieyal received his Ph.D. in pharmacology from New York Medical College, a B.A. in chemistry and psychology from Case Western Reserve University, and is a Chartered Financial Analyst.